Regulatory and Market Reports

Unlock the insights you need to stay ahead in the ever-evolving landscape of state and federal regulations and market trends. Our comprehensive reports provide invaluable data-driven analysis, giving you a competitive edge in understanding compliance requirements and industry shifts. Stay informed, stay compliant, and stay ahead of the curve with our expertly curated reports.

or reach out to us at [email protected] for more information.

This report provides an overview of the federal regulations that apply to infusion centers, including considerations for payment, coverage, drug acquisition, claim submissions, and compliance.

These reports provide an overview of regulations in a given state, including who may provide infusion services and order/administer infusion drugs, corporate structure and ownership, clinic licensing, pharmacy licensing, and fraud and abuse.

This quarterly report contains all non-oncology, infusible, and injectable medications in Phase III clinical trials or later, plus a detailed analysis including an executive summary and information statistics on market status, technology, route of administration, indication, therapeutic category, specialty, and administration method.

This annual report offers a detailed analysis of current and future trends in the U.S. non-oncology biopharmaceuticals market. Gain valuable insights for market expansion and marketing strategies to meet future patient demand for provider-administered therapies. Understand key market players, trends, and opportunities to enhance patient care.

This quarterly report contains all currently marketed provider-administered medications. It contains scientific and brand names, distributors, categories, routes, common indications, billing codes, and billing units.